Rhelion Life Sciences Corp. (CSE:RHEL)

Rhelion Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	2.6	8.47	12.27	14.17	18.49	26.09
Short-Term Investments	5.53	0.58	-	-	0.05	0.53
Cash & Short-Term Investments	8.13	9.05	12.27	14.17	18.53	26.62
Cash Growth	-30.34%	-26.24%	-13.40%	-23.53%	-30.39%	-18.54%
Accounts Receivable	0.4	0.45	0.4	0.52	0.52	0.38
Other Receivables	0.06	0.03	0	0.52	0.37	0.14
Receivables	0.45	0.48	0.4	1.04	0.88	0.52
Inventory	0.38	0.85	1	0.87	0.74	0.38
Prepaid Expenses	0.22	0.18	0.49	0.78	2.05	0.22
Restricted Cash	-	-	0.57	0.2	-	-
Other Current Assets	1.9	1.9	-	-	-	-
Total Current Assets	11.09	12.46	14.74	17.07	22.21	27.75
Property, Plant & Equipment	1.81	1.52	5.68	5.66	5.39	3.08
Long-Term Investments	1.84	0.6	0.78	1.02	0.87	0.68
Goodwill	6.66	-	-	0.28	1.31	0.72
Other Intangible Assets	0.46	-	0.02	0.05	0.34	0.59
Other Long-Term Assets	-	-	-	-	0.03	0.11
Total Assets	21.86	14.57	21.22	24.08	30.14	32.94

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1.46	0.63	0.63	0.92	0.62	0.46
Accrued Expenses	0.71	1.3	0.74	0.76	0.67	0.92
Short-Term Debt	1.16	1.13	1.13	0.91	0.91	0.91
Current Portion of Long-Term Debt	-	-	0.65	0.39	0.26	0.39
Current Portion of Leases	0.08	0.06	0.08	0.13	0.18	0.06
Current Income Taxes Payable	-	-	0.03	0	-	-
Other Current Liabilities	-	-	-	0.01	0.05	-
Total Current Liabilities	3.41	3.13	3.26	3.12	2.68	2.73
Long-Term Leases	0.21	0.22	0.32	0.29	0.42	0.15
Long-Term Deferred Tax Liabilities	-	-	0.3	0.41	0.51	0.6
Other Long-Term Liabilities	-	-	-	-	0.19	0.29
Total Liabilities	3.82	3.35	3.87	3.82	3.8	3.78

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	51.38	43.84	43.34	42.44	41.79	38.29
Additional Paid-In Capital	6.15	5.29	5.12	4.93	3.83	4.76
Retained Earnings	-50.17	-48.3	-42.2	-38.14	-30.53	-25.13
Comprehensive Income & Other	11.45	11.14	11.09	10.84	10.98	10.57
Total Common Equity	18.81	11.97	17.35	20.07	26.06	28.48
Minority Interest	-0.77	-0.75	-0	0.19	0.28	0.68
Shareholders' Equity	18.04	11.22	17.35	20.26	26.34	29.16
Total Liabilities & Equity	21.86	14.57	21.22	24.08	30.14	32.94

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1.45	1.42	2.18	1.72	1.77	1.5
Net Cash (Debt)	7.29	8.23	10.87	13.48	17.63	25.8
Net Cash Growth	-33.25%	-24.25%	-19.37%	-23.55%	-31.67%	-19.15%
Net Cash Per Share	0.02	0.02	0.03	0.03	0.05	0.07
Filing Date Shares Outstanding	614.12	614.12	412.25	393.79	387.89	358.17
Total Common Shares Outstanding	614.12	425.71	410.85	393.79	387.89	358.17
Working Capital	7.68	9.33	11.48	13.95	19.52	25.02
Book Value Per Share	0.03	0.03	0.04	0.05	0.07	0.08
Tangible Book Value	11.68	11.97	17.33	19.74	24.41	27.16
Tangible Book Value Per Share	0.02	0.03	0.04	0.05	0.06	0.08
Land	0.02	0.02	1.94	-	1.57	0.04
Buildings	1.25	1.25	2.94	3.07	2.97	2.49
Machinery	1.62	1.03	1.25	2.76	0.64	0.49
Leasehold Improvements	-	-	-	-	-	0.02

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 20, 2026

Data Sources Report a data error